Recursion Pharmaceuticals Inc Clas (RXRX)

Total Costs & Expenses

$598.86M

TTM · Period ending: · USD

RXRX logo

RXRX Total Costs & Expenses

Latest reported$598.86M
RXRX Total Costs & Expenses ($64.15M → $598.86M)
High-resolution chart · PNG

RXRX total costs & expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas Total Costs & Expenses — Annual fiscal periods (USD)
Period endingTotal Costs & Expenses (USD)
722,813,000
537,843,000
393,936,000
285,408,000
192,775,000
88,028,000
64,152,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.